Comparative Pharmacology
Head-to-head clinical analysis: SULLA versus SULSTER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SULLA versus SULSTER.
SULLA vs SULSTER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
SULLA (sulfamethoxazole/trimethoprim) inhibits bacterial dihydropteroate synthase and dihydrofolate reductase, sequentially blocking folate synthesis and thereby nucleic acid production.
Sulster is a sulfonamide antibiotic that inhibits bacterial dihydropteroate synthase, blocking folate synthesis and thus bacterial DNA replication.
100 mg orally once daily, increased to 200 mg daily if needed.
2.5 mg orally twice daily.
None Documented
None Documented
6-12 hours; prolonged in renal impairment (up to 30 hours)
Terminal half-life 3.5-4.5 hours in normal renal function; prolonged to 10-15 hours with creatinine clearance <30 mL/min.
Renal: 70-90% unchanged; biliary/fecal: 5-10%
Primarily renal (60-70% unchanged), with 20-30% as glucuronide conjugate; biliary/fecal <10%.
Category C
Category C
Sulfonamide Antibiotic
Sulfonamide Antibiotic